| 1 | LLY | Eli Lilly and Company | 19.37% |
| 2 | NVO | Novo Nordisk A/S | 14.39% |
| 3 | VKTX | Viking Therapeutics, Inc. | 6.38% |
| 4 | SWX: ROG | Roche Holding AG | 5.62% |
| 5 | ZEAL.DC | Zealand Pharma A/S | 5.57% |
| 6 | 4519.JP | Chugai Pharmaceutical Co Ltd | 5.44% |
| 7 | GPCR | Structure Therapeutics Inc. | 5.34% |
| 8 | AMGN | Amgen Inc. | 4.03% |
| 9 | AZN | AstraZeneca PLC | 3.86% |
| 10 | PFE | Pfizer Inc. | 3.84% |
| 11 | HKG: 1801 | Innovent Biologics, Inc. | 3.69% |
| 12 | REGN | Regeneron Pharmaceuticals, Inc. | 3.44% |
| 13 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 3.21% |
| 14 | SRRK | Scholar Rock Holding Corporation | 3.07% |
| 15 | GUBRA.DC | Gubra A/S | 2.76% |
| 16 | RYTM | Rhythm Pharmaceuticals, Inc. | 1.88% |
| 17 | GILD | Gilead Sciences, Inc. | 1.85% |
| 18 | HKG: 3933 | The United Laboratories International Holdings Limited | 1.73% |
| 19 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 1.39% |
| 20 | 4507.JP | Shionogi & Co Ltd | 1.33% |
| 21 | BHVN | Biohaven Ltd. | 1.20% |
| 22 | JPY | Lazard Japanese Equity ETF | 0.01% |
| 23 | n/a | n/a | n/a |
| 24 | n/a | n/a | n/a |
| 25 | n/a | n/a | n/a |
| View OZEM holdings |
